<![CDATA[Virpax Pharmaceuticals Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=38630>Fri, 01 May 2026 08:51:23 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock]]>https://www.newswire.co.kr/newsRead.php?no=930771Fri, 17 Sep 2021 14:45:00 +0900<![CDATA[버팍스파마슈티컬스, 4000만달러 상당 보통주 공모 마감]]>https://www.newswire.co.kr/newsRead.php?no=930772Fri, 17 Sep 2021 14:45:00 +0900<![CDATA[Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock]]>https://www.newswire.co.kr/newsRead.php?no=930622Thu, 16 Sep 2021 09:30:00 +0900<![CDATA[버팍스 파마슈티컬스, 총 4000만달러의 보통주 공모가 발표]]>https://www.newswire.co.kr/newsRead.php?no=930623Thu, 16 Sep 2021 09:30:00 +0900